双特异性抗体研究进展

Research progress in bispecific antibodies

ES评分 0

DOI 10.12208/j.imrf.20240011
刊名
International Medical Research Frontier
年,卷(期) 2024, 8(2)
作者
作者单位

南京医科大学国家卫生健康委员会抗体技术重点实验室 江苏南京 ;

摘要
双特异性抗体(bispecific antibody,BsAb)是一种含有两个独立抗原结合位点的抗体,具有能够同时结合两个不同抗原或同一抗原的两个不同表位的功能。根据其分子中是否含有Fc段,可分为IgG样BsAb,非IgG样BsAb。由于IgG样的BsAb分子与天然的IgG具有更为相似的分子结构,因此其表现出较长的循环半衰期,且较不容易对该BsAb引起免疫反应。非IgG样BsAb由于不含天然抗体的Fc段,分子量较小,肿瘤渗透性较好,能够更大幅度缩短特异性免疫细胞和肿瘤细胞的间距,在肿瘤杀伤方面发挥更为显著的作用,但缺点是其半衰期较短。本文将对BsAb的分子结构,作用机制及临床应用等方面进行综述。
Abstract
Bispecific antibody ( BsAb) is a kind of antibody with two different antigen binding arms. It has the ability to bind two different antigens or two different epitopes of one antigen at the same time. According to whether it contains Fc fragment, it can be divided into IgG-like BsAb and non-IgG-like BsAb. IgG-like BsAb has a longer half-life and is less likely to elicit immune responses against IgG-like BsAb due to its molecular form closer to that of natural antibodies. Non-IgG-like BsAb has a small molecular weight and better tumor permeability because it does not contain the Fc fragment of natural antibody. It can significantly shorten the spacing between specific immune cells and tumor cells and play a more significant tumor killing effect. But the disadvantage is its short half-life. This review provides insight into the molecular structure, mechanism and clinical application of bispecific antibody.
关键词
双特异性抗体;分子结构;抗体制备;临床应用
KeyWord
Bispecific antibody; Molecular structure; Antibody preparation; Clinical application
基金项目
页码 1-8
  • 参考文献
  • 相关文献
  • 引用本文

沈洪彪*,黄雨譞,唐奇. 双特异性抗体研究进展 [J]. 国际医药研究前沿. 2024; 8; (2). 1 - 8.

  • 文献评论

相关学者

相关机构